# The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia

> **NCT00222833** · PHASE4 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 30 (—)

## Conditions studied

- Overweight
- Hyperlipidemia
- Cardiovascular Diseases

## Interventions

- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT00222833
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 30 (—)
- **Last updated:** 2008-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00222833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00222833, "The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00222833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*